October Pharma
October Pharma operates in various business sectors.
Market Cap & Net Worth: October Pharma (OCPH)
October Pharma (EGX:OCPH) has a market capitalization of $37.00K (EGP1.87 Million) as of March 18, 2026. Listed on the EGX stock exchange, this Egypt-based company holds position #42874 globally and #19 in its home market, demonstrating a 1.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying October Pharma's stock price EGP191.70 by its total outstanding shares 9758 (9.76K).
October Pharma Market Cap History: 2017 to 2026
October Pharma's market capitalization history from 2017 to 2026. Data shows growth from $5.55K to $37.00K (36.91% CAGR).
October Pharma Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how October Pharma's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of OCPH by Market Capitalization
Companies near October Pharma in the global market cap rankings as of March 18, 2026.
Key companies related to October Pharma by market ranking:
- INTEVAC (BE:IV2): Ranked #42865 globally with a market cap of $35.96K USD ( €35.03K EUR).
- KINGFISHER (BE:KFI1): Ranked #42866 globally with a market cap of $35.95K USD ( €35.02K EUR).
- Brookfield India Real Estate Trust (NSE:BIRET-RR): Ranked #42875 globally with a market cap of $35.76K USD ( ₹3.10 Million INR).
- C V D EQUIPMENT (0V3.SG) (STU:0V3): Ranked #42876 globally with a market cap of $35.76K USD ( €34.83K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #42865 | INTEVAC | BE:IV2 | $35.96K | €3.60 |
| #42866 | KINGFISHER | BE:KFI1 | $35.95K | €3.58 |
| #42875 | Brookfield India Real Estate Trust | NSE:BIRET-RR | $35.76K | ₹332.69 |
| #42876 | C V D EQUIPMENT (0V3.SG) | STU:0V3 | $35.76K | €3.56 |
October Pharma Historical Marketcap From 2017 to 2026
Between 2017 and today, October Pharma's market cap moved from $5.55K to $ 37.00K, with a yearly change of 36.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | EGP37.00K | -6.18% |
| 2025 | EGP39.43K | +87.21% |
| 2024 | EGP21.06K | +9.14% |
| 2023 | EGP19.30K | 0.00% |
| 2022 | EGP19.30K | -38.66% |
| 2021 | EGP31.46K | +63.02% |
| 2020 | EGP19.30K | +51.52% |
| 2019 | EGP12.74K | +3.61% |
| 2018 | EGP12.29K | +121.47% |
| 2017 | EGP5.55K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of October Pharma was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $37.00K USD |
| MoneyControl | $37.00K USD |
| MarketWatch | $37.00K USD |
| marketcap.company | $37.00K USD |
| Reuters | $37.00K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.